<code id='A461E7CD10'></code><style id='A461E7CD10'></style>
    • <acronym id='A461E7CD10'></acronym>
      <center id='A461E7CD10'><center id='A461E7CD10'><tfoot id='A461E7CD10'></tfoot></center><abbr id='A461E7CD10'><dir id='A461E7CD10'><tfoot id='A461E7CD10'></tfoot><noframes id='A461E7CD10'>

    • <optgroup id='A461E7CD10'><strike id='A461E7CD10'><sup id='A461E7CD10'></sup></strike><code id='A461E7CD10'></code></optgroup>
        1. <b id='A461E7CD10'><label id='A461E7CD10'><select id='A461E7CD10'><dt id='A461E7CD10'><span id='A461E7CD10'></span></dt></select></label></b><u id='A461E7CD10'></u>
          <i id='A461E7CD10'><strike id='A461E7CD10'><tt id='A461E7CD10'><pre id='A461E7CD10'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:364
          Photography of the US department of health and human services in Silver Spring MD
          Manuel Balce Ceneta/AP

          An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

          Triple-check your data or we’ll reject your device, the FDA warned.

          advertisement

          The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          Ukraine seeks to reclaim its role as a hub for clinical trials
          Ukraine seeks to reclaim its role as a hub for clinical trials

          AtUkraine'sDniproStateMedicalUniversity(picturedherein2013),therehasn’tbeenanewcancerdrugtrialstarte

          read more
          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more

          The creative science of coining drug names

          GarethCattermole/GettyImagesCialis,Eliquis,Jevtana,Xgeva.Thesedrugnamesmaysoundsilly,buttheprocessof